Biological Functions of Regulatory T Cells

Advances in Immunology

Volumn 112, Issue , 2011, Pages 137-176

  Shevach, Ethan M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Dendritic cells; Regulatory T cells; Suppression

Indexed keywords

B7 ANTIGEN; CD3 ANTIBODY; CD40 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY CD28; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE GASTRITIS; AUTOIMMUNITY; BIOLOGICAL ACTIVITY; CELL EXPANSION; CYTOKINE PRODUCTION; DENDRITIC CELL; EFFECTOR CELL; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNE DEFICIENCY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE TRANSFER; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TARGET CELL; TH17 CELL; TRANSCRIPTION REGULATION;

EID: 82155171374     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/B978-0-12-387827-4.00004-8     Document Type: Chapter

References (71)

1. Barthlott T., Kassiotis G., Stockinger B. T cell regulation as a side effect of homeostasis and competition. J. Exp. Med. 2003, 197:451-460.
2. Belkaid Y., Rouse B.T. Natural regulatory T cells in infectious disease. Nat. Immunol. 2005, 6:353-354.
3. Billiard F., Litvinova E., Saadoun D., Djelti F., Klatzmann D., Cohen J.L., Marodon G., Salomon B.L. Regulatory and effector T cell activation levels are prime determinants of in vivo immune regulation. J. Immunol. 2006, 177:2167-2174.
4. + regulatory T cell down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 2000, 30:1538-1543.
5. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 2003, 198:1875-1886.
6. + T cells in vivo. J. Immunol. 2011, 186:6329-6337.
7. Curotto de Lafaille M.A., Lafaille J.J. Natural and adaptive Foxp3+ regulatory T cells: More of the same or a division of labor?. Immunity 2009, 30:626-635.
8. Davidson T.S., Shevach E.M. Polyclonal Tregs modulate T effector cell trafficking. Eur. J. Immunol. 2011, 41:2862-2870.
9. Davidson T.S., DiPaolo R.J., Andersson J., Shevach E.M. Cutting Edge: IL-2 is essential for TGF-β-induction of Foxp3+ T regulatory cells. J. Immunol. 2007, 178:4022-4026.
10. D'elios M.M., Bergman M.P., Azzurri A., Amedei A., Benagiano M., De Pont J.J., Cianchi F., Vandenbroucke-Grauls C.M., Romagnani S., Appelmelk B.J., Del Prete G. H+, K+-ATPase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology 2001, 120:377-386.
11. Ding L., Linsley P.S., Huang L.Y., Germain R.N., Shevach E.M. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 1993, 151:1224-1234.
12. + T cells prevent the development of organ-specific autoimmune disease by inhibiting the differentiation of autoreactive effector T cells. J. Immunol. 2005, 175:7135-7142.
13. + regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating T cells. J. Immunol. 2007, 179:4685-4693.
14. + regulatory T cells in the steady state. J. Exp. Med. 2003, 198:737-746.
15. + regulatory T cells. Nat. Immunol. 2003, 4:330-336.
16. Godebu E., Summers-Torres D., Lin M.M., Baaten B.J.G., Bradley L.M. Polyclonal adaptive regulatory CD4 cells that can reverse type I diabetes become oligoclonal long-term protective memory cells. J. Immunol. 2008, 181:1798-1805.
17. Grigorova I.L., Scheab S.R., Phan T.H.M., Okada T., Cyster J.G. Cortical sinus probing, S1P1-dependent entry and flow-based capture of egressing T cells. Nat. Immunol. 2009, 10:58-65.
18. Hanig J., Lutz M.B. Suppression of mature dendritic cell function by regulatory T cells in vivo is abrogated by CD40 licensing. J. Immunol. 2008, 180:1405-1413.
19. Haribhai D., Williams J.B., Jia S., Nickerson D., Schmitt E.G., Edwards B., Ziegelbauer J., Yassai M., Li S.H., Relland L.M., Wise P.M., Chen A., et al. A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity 2011, 35:109-122.
20. Hirota K., Duarte J.H., Veldhoen M., Hornsby E., Li Y., Cua D.J., Ahifors H., Wilhelm C., Tolaini M., Menzel U., Garefalaki A., Potocnik A.J., et al. Fate mapping of IL-17-producing cells in inflammatory responses. Nat. Immunol. 2011, 12:255-263.
21. + regulatory T cells. Nat. Med. 2004, 10:29-30.
22. + T cells. Adv. Immunol. 2003, 81:331-371.
23. + regulatory T cells rescue scurfy mice. Eur. J. Immunol. 2008, 38:1814-1821.
24. Huter E.N., Stumvoll G.H., DiPaolo R.J., Glass D.D., Shevach E.M. Cutting edge: Antigen-specific TGFβ-induced regulatory T cells suppress Th17-mediated autoimmune disease. J. Immunol. 2008, 181:8209-8213.
25. Josefowicz S.Z., Rudensky A. Control of regulatory T cell lineage commitment and maintenance. Immunity 2009, 30:616-625.
26. Kim J.M., Rasmussen J.P., Rudensky A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of the mouse. Nat. Immunol. 2007, 8:191-197.
27. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 2002, 168:1080-1086.
28. Klein L., Khazaie K., von Boehmer H. In vivo dynamics of antigen-specific regulatory T cell not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA 2003, 100:8886-8891.
29. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 2002, 169:4712-4716.
30. + regulatory T cells induces a scurfy-like disease. J. Exp. Med. 2007, 204:57-63.
31. Lohr J., Knoechel B., Wang J.J., Villarino A.V., Abbas A.K. Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J. Exp. Med. 2006, 203:2785-2791.
32. Longley R.L., Woods A., Fleetwood A., Cowling G.J., Gallagher J.T., Couchman J.T. Control of morphology, cytoskeleton and migration by syndecan-4. Cell Sci. 1999, 112:3421-3431.
33. Lund J.M., Hsing L., Pham T.T., Rudensky A.Y. Coordination of early protective to viral infection by regulatory T cells. Science 2008, 320:1220-1224.
34. + regulatory cells within the central nervous system. J. Immunol. 2005, 175:3025-3032.
35. + T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. 2004, 172:4676-4680.
36. Morlacchi S., Dal Secco V., Soldani C., Glaichenhaus N., Viola A., Sarukhan A. Regulatory T cells target chemokine secretion by dendritic cells independently of their capacity to regulate T cell proliferation. J. Immunol. 2011, 186:6807-6814.
37. O'Gorman W.E., Dooms H., Thorne S.H., Kuswanto W.F., Simonds E.F., Krutzik P.O., Nolan G., Abbas A.K. The initial phase of an immune response functions to activate regulatory T cells. J. Immunol. 2009, 183:332-339.
38. + regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo. J. Exp. Med. 2003, 198:259-266.
39. + natural regulatory cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. USA 2008, 105:10113-10118.
40. Quinn K.M., Rich F.J., Goldsak L.M., de Lisle G.W., Buddle B.M., Delahunt B., Kirman J.R. Accelerating the immune response by inactivating CD4+CD25+ IT regulatory T cells prior to BCG vaccination does not enhance protection against TB. Eur. J. Immunol. 2008, 38:695-705.
41. Qureshi O.S., Zheng Y., Nakamura K., Attridge K., Manzotti C., Schmidt E.M., Baker J., Jeffery L.E., Kaur S., Briggs Z., Hou T.Z., Futter C.E., et al. Trans-endocytosis of CD80 and CD86: A molecular basis for the cell-extrinsic function of CTLA-4. Science 2011, 332:600-603.
42. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): Breakdown of a single mechanism of self-toleracne causes various autoimmune diseases. J. Immunol. 1995, 155:1151-1164.
43. Sakaguchi S., Yamaguchi T., Namura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 135:775-787.
44. + regulatory T cells in the regional lymph node. J. Exp. Med. 2005, 202:771-781.
45. Sarris M., Anderson K.G., Randow F., Mayr L., Betz A.G. Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 2008, 28:402-413.
46. Scheinecker C., McHugh R., Shevach E.M., Germain R.E. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 2002, 196:1079-1090.
47. + regulatory T lymphocytes through the induction of anergy and infectious tolerance. J. Immunol. 2008, 180:2830-2838.
48. + T cells. Immunity 2003, 19:877-889.
49. + T regulatory cell-mediated suppression. Immunity 2009, 30:636-645.
50. + regulatory T cells. Immunol. Rev. 2006, 212:60-73.
51. Shimizu J., Yamazaki S., Sakaguchi S. Induction of tumor immunity by removing CD25+CD4+ T cells: A common basis between tumor immunity and autoimmunity. J. Immunol. 1999, 163:5211-5218.
52. + T-cell-dependent immune defense of B16 melanoma. Cancer Res. 2001, 61:8643-8646.
53. Stephens G.L., Andersson J., Shevach E.M. Distinct subsets of FoxP3+ regulatory T cells participate in the control of immune responses. J. Immunol. 2007, 178:6901-6911.
54. Stummvoll G.H., DiPaolo R.J., Huter E., Davidson T.S., Glass D., Ward J.M., Shevach E.M. Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. J. Immunol. 2008, 181:1908-1916.
55. Sumoza-Toledo A., Eaton A.D., Sarukhan A. Regulatory T cells inhibit protein kinase Cθ recruitment to the immune synapse of naïve T cells with the same antigen specificity. J. Immunol. 2006, 176:5779-5787.
56. Suvas S., Kumaraguru U., Pack C.D., Lee S., Rouse B.T. CD4+ CD25+T cells regulate virus-specific primary and memory CD8+ T cell responses. J. Exp. Med. 2003, 198:889-901.
57. Tadoko C.E., Shakar G., Shen S., Ding Y., Lino A.C., Maraver A., Lafaille J.J., Dustin M.L. Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J. Exp. Med. 2006, 203:505-511.
58. Tang Q., Henriksen K.J., Bi M., Finger E.B., Szot G., Ye J., Masteller E.J., McDevitt H., Bonayhadi M., Bluestone J.E. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 2004, 199:1467-1477.
59. Tang Q., Adams J.Y., Tooley A.J., Bi M., Fife B.T., Serra P., Santamaria P., Locksley R.M., Krummerl M.F., Bluestone J.A. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 2006, 7:83-92.
60. + immune regulatory cells inhibits graft-vs-host disease (GVHD) lethality. Blood 2002, 99:4601-4609.
61. Thangada S., Khanna K.M., Blaho V.A., Oo M.L., Im D.S., Guo C.Y., Lefrancois L., Hla T. Cell surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics. J. Exp. Med. 2010, 207:1475-1483.
62. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin-2 production. J. Exp. Med. 1998, 188:287-296.
63. + T cells in gut Peyer's patches. Science 2009, 323:1488-1492.
64. + T cells. J. Immunol. 2006, 176:6202-6210.
65. Vendetti S., Riccomi A., Negri D.R., Veglia F., Sciaraffia E., de Magistris M.T. Development of antigen-specific T cells in mediastinal lymph nodes after intranasal immunization. Methods 2009, 49:334-339.
66. Vendetti S., Davidson T.S., Veglia F., Riccomi A., Negri D.R.M., Lindstedt R., Pasquali P., Shevach E.M., De Magistris M.T. Polyclonal Treg cells enhance the activity of a mucosal adjuvant. Immunol. Cell Biol. 2010, 88:698-706.
67. + regulatory T cells in vivo. J. Exp. Med. 2003, 198:249-258.
68. Weber S.E., Harbertson J., Godebu E., Mros G.A., Padrick R.C., Carson B.D., Ziegler S.F., Bradley L.M. Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo. J. Immunol. 2006, 176:4730-4739.
69. - T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-β. J. Immunol. 2007, 178:6725-6729.
70. Zhang H., Podojil J.R., Chang J., Luo X., Miller S.D. TGF-β-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis. J. Immunol. 2010, 184:6629-6636.
71. + T cells selectively kill B lymphocytes. Blood 2006, 107:3925-3932.